MEREDITH LEE: Open Payments
NPI 1689115727 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 11 payments from 9 companies in 2025. Trend: 2023 $32 · 2024 $71 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| SANOFI-AVENTIS U.S. LLC | 2 | $32 |
| Averitas Pharma Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $22 |
| Insulet Corporation | 1 | $21 |
| Medtronic, Inc. | 1 | $20 |
| Mannkind Corporation | 1 | $20 |
| BTG International Inc. | 1 | $15 |
Products named: RECORLEV, TZIELD, QUTENZA, Kerendia, LEQEMBI, Omnipod, MINIMED 780G, AFREZZA.
Industry payments across AL — which companies pay providers there.
